Prostate cancer: Is fracture prevention therapy cost-effective in patients with prostate cancer treated with ADT?

被引:0
|
作者
Warde N.
机构
关键词
D O I
10.1038/nrurol.2010.90
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:363 / 363
相关论文
共 50 条
  • [12] Cost-effective analysis of supervised exercise training in men with prostate cancer previously treated with androgen deprivation therapy and radiation
    Edmunds, Kim
    Reeves, Penny
    Tuffaha, Haitham
    Galvao, Daniel
    Newton, Rob
    Spry, Nigel
    Denham, James
    Taaffe, Dennis R.
    Joseph, David
    Lamb, David S.
    Chambers, Suzanne K.
    Scuffham, Paul
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 63 - 63
  • [13] Is the IMRT for Prostate Cancer a Cost Driver or a cost-effective Method? A critical Review
    Schaefer, C.
    Allgaeuer, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 : S55 - S55
  • [14] Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer
    Konski, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1373 - 1378
  • [15] Value of a systematic cardiac workup by a cardiologist for prostate cancer patients treated with ADT
    Roge, M.
    Guimas, V.
    Supiot, S.
    Mervoyer, E. Martin
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1197 - S1198
  • [16] Skeletal Muscle Loss after Short ADT Duration in Prostate Cancer Patients Treated with Radiation Therapy
    Gadam, R. K.
    Gibson, S. M.
    Cao, Y.
    Shen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E361 - E361
  • [17] COST-EFFECTIVE PRIORITIES FOR CANCER PREVENTION
    WEINSTEIN, MC
    SCIENCE, 1983, 221 (4605) : 17 - 23
  • [18] Intensity modulated radiation therapy (IMRT) is a cost-effective treatment for intermediate risk prostate cancer
    Konski, AA
    Watkins-Bruner, D
    Feigenberg, S
    Hanlon, A
    Kulkarni, S
    Beck, J
    Pollack, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S144 - S144
  • [19] Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?
    Vanneste, Ben G. L.
    Pijls-Johannesma, Madelon
    Van De Voorde, Lien
    van Lin, Emile N.
    van de Beek, Kees
    van Loon, Judith
    Ramaekers, Bram L.
    Lambin, Philippe
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 276 - 281
  • [20] Added value of Spacer to IMRT treatment of prostate cancer: Is it cost-effective?
    Vanneste, B. G. L.
    Pijls-Johannesma, M.
    Smits, K. M.
    Lutgens, L.
    Houben, R.
    Hoffmann, A.
    Van De Voorde, L.
    Van Lin, E.
    Ramaekers, B.
    Lambin, P.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S134 - S134